Biosensor for Early Detection of Preeclampsia
Author Information
Author(s): Josep Maria Cantons, Akash Bachhuka, Lluis F. Marsal
Primary Institution: Rovira I Virgili University (URV)
Hypothesis
Can a hybrid biosensor platform using gold nanoclusters and nanoporous anodic alumina effectively detect endoglin for early diagnosis of preeclampsia?
Conclusion
The developed biosensor demonstrated a linear detection range for endoglin from 10 to 50 ng/mL and a limit of detection of 5.4 ng/mL, indicating its potential for early preeclampsia diagnosis.
Supporting Evidence
- Preeclampsia affects 5-8% of pregnant women globally and is a leading cause of maternal and fetal morbidity.
- Endoglin levels exceeding 20 ng/mL are associated with a significantly increased risk of preeclampsia.
- The biosensor showed a limit of detection of 5.4 ng/mL for endoglin, indicating high sensitivity.
- The biosensor's selectivity was validated against common proteins, showing minimal non-specific binding.
Takeaway
Scientists created a special sensor that can quickly find a protein linked to a pregnancy problem called preeclampsia, helping doctors catch it early.
Methodology
The biosensor was developed by integrating nanoporous anodic alumina with gold nanoclusters, followed by functionalization with antibodies specific to endoglin.
Limitations
The study primarily focuses on the biosensor's performance in controlled conditions, and further validation in real biological samples is needed.
Statistical Information
P-Value
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website